Methylene Blue (oral supplement) for Longevity and Anti-Aging: Protocol, Dosing, and What to Expect
Evidence strength: moderate
What this protocol is for
Methylene blue for longevity is mechanism-driven and increasingly mainstream in the longevity supplement space. The molecule supports mitochondrial electron transport, reduces oxidative stress at the mitochondrial level, and has neuroprotective effects relevant to age-related cognitive decline. Mitochondrial dysfunction is one of the most well-characterised hallmarks of aging; methylene blue addresses it through a different mechanism than NAD+ precursors or MOTS-c, making it a useful stack component rather than a competitor.
The clinical pattern in user reports tracks the mechanism. Sustained cognitive function in users past 50, particularly for sustained-attention tasks. Less age-related fatigue accumulation through the day. Anecdotal reports of preserved cognitive sharpness over years of continued use. The longevity-specific clinical trials are limited, but the underlying biology (mitochondrial electron transport support, reduced oxidative stress) maps onto well-characterised aging biology.
Used by many in the recovery / biohacking space as one of the lower-cost, mechanism-supported longevity layers. Run this as a tactical, legal performance layer in a multi-pronged longevity stack. The molecule is among the easier additions: oral, well-tolerated at the supplement-dose range, no injection required, no major interaction issues at typical doses (excluding the SSRI watch-point). For cost-effective mitochondrial-aging support, methylene blue earns its place.
Dose for longevity and anti-aging
5 to 15 mg oral daily for longevity-focused use. The lower end of the cognitive-dose range is sufficient because the goal is sustained mitochondrial support rather than acute cognitive performance. Morning dosing is standard; consistency matters more than timing for longevity protocols.
Cycle length
Continuous low-dose use is common at the longevity-focused dose range (5 to 10 mg daily). Some users cycle 12 weeks on, 4 weeks off as a precaution; the clinical evidence does not strongly support cycled versus continuous use at the supplement-dose range.
Stack pairings
Commonly stacked with NAD+ (oral supplement).
Expected timeline
Week 1–4: subjective improvements in mental clarity and sustained cognitive function. Reduced afternoon fatigue. Week 4–12: cumulative cognitive stability builds. Long-term (months to years): neuroprotective effects accumulate with continued use; the mitochondrial-aging case is built on cumulative effect across years rather than single-cycle change.
Common mistakes
- Running methylene blue at high doses for longevity expecting proportional benefit. The U-shaped dose-response curve means higher is not better. Stay at the 5 to 15 mg range for longevity use; reserve the upper end of the cognitive range for acute cognitive demand.
- Combining with active SSRI or serotonergic medication for longevity without clinician input. The theoretical interaction risk is the main safety watch-point.
- Treating methylene blue as a standalone longevity protocol. The molecule is one mitochondrial-aging layer; other layers (NAD+ precursors, exercise, sleep, nutrition) address non-overlapping slices of the longevity question.
- Inconsistent dosing. The longevity case for methylene blue is built on sustained mitochondrial support over years. Sporadic use does not deliver the cumulative effect the mechanism is designed for.